SeLux Diagnostics Patents – Insights & Stats (Updated 2023)

SeLux Diagnostics has a total of 177 patents globally, out of which 25 have been granted. Of these 177 patents, more than 55% patents are active. The United States of America is where SeLux Diagnostics has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of SeLux Diagnostics.

SeLux Diagnostics was founded in 2014. SeLux Diagnostics manufactures universal synthetic amplifier technology equipment. The company provides the Next Generation Phenotyping (NGP) technology, which has the potential to revolutionize the treatment of patients with infectious diseases by vastly improving the precision and speed with which specific, individualized antibiotic regimens may be provided.

Do read about some of the most popular patents of SeLux Diagnostics which have been covered by us in this article and also you can find SeLux Diagnostics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SeLux Diagnostics patent portfolio.

How many patents does SeLux Diagnostics have?

SeLux Diagnostics has a total of 177 patents globally. These patents belong to 31 unique patent families. Out of 177 patents, 99 patents are active.

How Many Patents did SeLux Diagnostics File Every Year?

SeLux Diagnostics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSeLux Diagnostics Applications FiledSeLux Diagnostics Patents Granted
20231
202239
2021136
2020322
2019674
2018222
2017311
20166
20153

How many SeLux Diagnostics patents are Alive/Dead?

Worldwide Patents

SeLux Diagnostics Patent Portfolio

How Many Patents did SeLux Diagnostics File in Different Countries?

SeLux Diagnostics Worldwide Patent Filing

Countries in which SeLux Diagnostics Filed Patents

CountryPatent
United States Of America30
Europe22
Japan15
Australia14
Canada13
India10
China10
South Africa10
Israel7
Mexico7
Brazil7
Hong Kong (S.A.R.)2
Austria1
Spain1
United Kingdom1

Where are Research Centers of SeLux Diagnostics Patents Located?

R&D Centres of SeLux Diagnostics

10 Best SeLux Diagnostics Patents

US9834808B2 is the most popular patent in the SeLux Diagnostics portfolio. It has received 21 citations so far from company like CAP Diagnostics.

Below is the list of 10 most cited patents of SeLux Diagnostics:

Publication NumberCitation Count
US9834808B221
WO2018119439A118
WO2016015027A117
WO2017185012A116
US20180275058A114
WO2017127684A110
US10161948B27
WO2018144918A16
WO2019191328A16
US20190218591A14

What Percentage of SeLux Diagnostics US Patent Applications Were Granted?

SeLux Diagnostics (Excluding its subsidiaries) has filed 20 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 64.29%.

Below are the key stats of SeLux Diagnostics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for SeLux Diagnostics?

Law FirmTotal ApplicationsSuccess Rate
Goodwin Procter Llp1266.67%
Kdb Firm Pllc862.5%

What are SeLux Diagnostics key innovation segments?

What Technologies are Covered by SeLux Diagnostics?

The chart below distributes patents filed by SeLux Diagnostics in different countries on the basis of the technology protected in patents. It also represents the markets where SeLux Diagnostics thinks it’s important to protect particular technology inventions.

R&D Focus: How has SeLux Diagnostics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by SeLux Diagnostics?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.